1
|
S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.
|
Proc Natl Acad Sci U S A
|
1992
|
5.37
|
2
|
Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform.
|
Proc Natl Acad Sci U S A
|
1992
|
4.32
|
3
|
Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae.
|
J Biol Chem
|
1996
|
3.75
|
4
|
Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells.
|
J Biol Chem
|
1996
|
2.82
|
5
|
Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin.
|
J Biol Chem
|
1997
|
2.76
|
6
|
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
|
Proc Natl Acad Sci U S A
|
1993
|
2.32
|
7
|
Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase.
|
J Biol Chem
|
1997
|
1.99
|
8
|
The endothelial nitric-oxide synthase-caveolin regulatory cycle.
|
J Biol Chem
|
1998
|
1.91
|
9
|
Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes.
|
J Biol Chem
|
1995
|
1.80
|
10
|
Molecular cloning and characterization of human endothelial nitric oxide synthase.
|
FEBS Lett
|
1992
|
1.79
|
11
|
In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice.
|
J Cardiovasc Electrophysiol
|
2001
|
1.56
|
12
|
Nitric oxide and the control of firefly flashing.
|
Science
|
2001
|
1.56
|
13
|
Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin.
|
J Biol Chem
|
1999
|
1.55
|
14
|
Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.
|
J Clin Invest
|
1993
|
1.54
|
15
|
Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells.
|
J Biol Chem
|
2001
|
1.50
|
16
|
Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization.
|
J Biol Chem
|
1993
|
1.49
|
17
|
Agonist-modulated palmitoylation of endothelial nitric oxide synthase.
|
J Biol Chem
|
1995
|
1.43
|
18
|
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.
|
Schizophr Res
|
2001
|
1.37
|
19
|
Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha.
|
Am J Physiol
|
1991
|
1.35
|
20
|
Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase.
|
Proc Natl Acad Sci U S A
|
1999
|
1.35
|
21
|
Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase.
|
J Biol Chem
|
2000
|
1.35
|
22
|
Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes.
|
J Biol Chem
|
1997
|
1.33
|
23
|
Receptor-regulated translocation of endothelial nitric-oxide synthase.
|
J Biol Chem
|
1998
|
1.31
|
24
|
Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells.
|
Am J Physiol
|
1998
|
1.30
|
25
|
Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction.
|
J Biol Chem
|
2000
|
1.27
|
26
|
Culture and decontamination methods affecting enumeration of phages infecting Bacteroides fragilis in sewage.
|
Appl Environ Microbiol
|
1992
|
1.26
|
27
|
Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways.
|
J Biol Chem
|
2001
|
1.25
|
28
|
Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate.
|
J Biol Chem
|
1998
|
1.24
|
29
|
Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase.
|
Proc Natl Acad Sci U S A
|
1998
|
1.23
|
30
|
Agonist versus antagonist binding to alpha-adrenergic receptors.
|
Proc Natl Acad Sci U S A
|
1980
|
1.22
|
31
|
Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.
|
Biochemistry
|
1998
|
1.18
|
32
|
Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium.
|
J Clin Invest
|
1994
|
1.11
|
33
|
Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting.
|
Proc Natl Acad Sci U S A
|
1995
|
1.10
|
34
|
Differential regulation of the alpha 2-adrenergic receptor by Na+ and guanine nucleotides.
|
Nature
|
1980
|
1.09
|
35
|
Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.
|
Arch Neurol
|
2000
|
1.06
|
36
|
Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene.
|
Genomics
|
1994
|
1.05
|
37
|
Molecular cloning and characterization of cDNA encoding the GTP-binding protein alpha i and identification of a related protein, alpha h.
|
Proc Natl Acad Sci U S A
|
1986
|
1.05
|
38
|
Calcium-independent activation of endothelial nitric oxide synthase by ceramide.
|
Proc Natl Acad Sci U S A
|
1999
|
1.04
|
39
|
Expression and regulation of endothelial nitric oxide synthase.
|
Trends Cardiovasc Med
|
1997
|
1.03
|
40
|
Oligomerization of endothelial nitric oxide synthase. Evidence for a dominant negative effect of truncation mutants.
|
J Biol Chem
|
1995
|
1.02
|
41
|
Expression of constitutive endothelial nitric oxide synthase in human blood platelets.
|
Life Sci
|
1995
|
1.00
|
42
|
Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma.
|
Am J Physiol
|
1995
|
0.99
|
43
|
Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains.
|
Int J Dev Neurosci
|
2000
|
0.99
|
44
|
A chimeric transmembrane domain directs endothelial nitric-oxide synthase palmitoylation and targeting to plasmalemmal caveolae.
|
J Biol Chem
|
2000
|
0.98
|
45
|
Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells.
|
J Clin Invest
|
1992
|
0.97
|
46
|
Mapping protein-protein contact sites using cellulose-bound peptide scans.
|
Mol Divers
|
1996
|
0.97
|
47
|
Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface.
|
Placenta
|
1994
|
0.93
|
48
|
Cell-free desensitization of catecholamine-sensitive adenylate cyclase. Agonist- and cAMP-promoted alterations in turkey erythrocyte beta-adrenergic receptors.
|
J Biol Chem
|
1984
|
0.92
|
49
|
Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase.
|
J Mol Cell Cardiol
|
2000
|
0.91
|
50
|
Streptokinase therapy and cholesterol embolization.
|
Am J Med
|
1989
|
0.91
|
51
|
Interactions of agonists with platelet alpha 2-adrenergic receptors.
|
Endocrinology
|
1982
|
0.91
|
52
|
Effect of pertussis toxin on alpha 2-adrenoceptors: decreased formation of the high-affinity state for agonists.
|
FEBS Lett
|
1984
|
0.89
|
53
|
Differential degradation rates of the G protein alpha o in cultured cardiac and pituitary cells.
|
J Biol Chem
|
1990
|
0.88
|
54
|
Expression of the mammalian renal peptide transporter PEPT2 in the yeast Pichia pastoris and applications of the yeast system for functional analysis.
|
Mol Membr Biol
|
1998
|
0.88
|
55
|
Hormonal inhibition of adenylate cyclase. alpha 2 Adrenergic receptors promote release of [3H]guanylylimidodiphosphate from platelet membranes.
|
J Biol Chem
|
1982
|
0.88
|
56
|
Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes.
|
J Biol Chem
|
1997
|
0.87
|
57
|
Genes for two homologous G-protein alpha subunits map to different human chromosomes.
|
Hum Genet
|
1987
|
0.86
|
58
|
Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture.
|
Circ Res
|
1995
|
0.86
|
59
|
Mechanisms of hormone receptor-effector coupling: the beta-adrenergic receptor and adenylate cyclase.
|
Fed Proc
|
1982
|
0.85
|
60
|
[Near-infrared spectroscopy in psychiatry].
|
Nervenarzt
|
2004
|
0.85
|
61
|
Recombinant endothelial nitric oxide synthase: post-translational modifications in a baculovirus expression system.
|
Mol Pharmacol
|
1995
|
0.84
|
62
|
Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists.
|
Circ Res
|
1995
|
0.84
|
63
|
Plasma membrane receptors.
|
J Clin Invest
|
1983
|
0.84
|
64
|
Molecular pharmacology of adenylate cyclase-coupled alpha- and beta-adrenergic receptors.
|
Adv Cyclic Nucleotide Res
|
1981
|
0.83
|
65
|
Investigations on oxidative stress and therapeutical implications in dementia.
|
Eur Arch Psychiatry Clin Neurosci
|
1999
|
0.82
|
66
|
Endothelial nitric oxide synthase membrane targeting. Evidence against involvement of a specific myristate receptor.
|
J Biol Chem
|
1994
|
0.82
|
67
|
Different sedimentation properties of agonist- and antagonist-labelled platelet alpha 2 adrenergic receptors.
|
Biochem Biophys Res Commun
|
1981
|
0.82
|
68
|
Explanted vein grafts with an intact endothelium demonstrate reduced focal expression of endothelial nitric oxide synthase specific to atherosclerotic sites.
|
J Pathol
|
1996
|
0.81
|
69
|
[Future of mammography-based imaging].
|
Radiologe
|
2014
|
0.80
|
70
|
Gender and personality in alcoholism.
|
Arch Womens Ment Health
|
2003
|
0.80
|
71
|
The role of the NO pathway in the control of cardiac function.
|
J Card Fail
|
1996
|
0.80
|
72
|
More sweetness than light? A search for the causes of diabetic vasculopathy.
|
J Clin Invest
|
2001
|
0.79
|
73
|
Experimental evidence of a mechanical coupling between layers in an individual double-walled carbon nanotube.
|
Nano Lett
|
2011
|
0.79
|
74
|
The role of palmitoyl-protein thioesterase in the palmitoylation of endothelial nitric oxide synthase.
|
FEBS Lett
|
1997
|
0.79
|
75
|
Platelet alpha 2 adrenoceptor characteristics during the morning increase in platelet aggregability.
|
Eur Heart J
|
1992
|
0.78
|
76
|
Expression of a G protein subunit, alpha i-1, in Balb/c 3T3 cells leads to agonist-specific changes in growth regulation.
|
J Biol Chem
|
1991
|
0.78
|
77
|
Potency and sterility of anesthetic drugs in obstetric anesthesia.
|
Int J Obstet Anesth
|
2002
|
0.78
|
78
|
Multi-photon microscopy in the evaluation of human saphenous vein.
|
J Surg Res
|
2001
|
0.78
|
79
|
Nitric oxide synthesis in infantile hypertrophic pyloric stenosis.
|
N Engl J Med
|
1992
|
0.78
|
80
|
Formation of peroxynitrite in vascular endothelial cells exposed to cyclosporine A.
|
FASEB J
|
2001
|
0.77
|
81
|
Raman active phonons of identified semiconducting single-walled carbon nanotubes.
|
Phys Rev Lett
|
2006
|
0.77
|
82
|
In vitro antioxidant and radical scavenging of Guinean kinkeliba leaf (Combretum micranthum G. Don) extracts.
|
Nat Prod Res
|
2011
|
0.76
|
83
|
Impatient inpatient care.
|
N Engl J Med
|
2000
|
0.75
|
84
|
No lack of NO activity.
|
Science
|
1993
|
0.75
|
85
|
Ciliary neurotrophic factor (CNTF) genotypes: influence on choline acetyltransferase (ChAT) and acetylcholine esterase (AChE) activities and neurotrophin 3 (NT3) concentration in human post mortem brain tissue.
|
J Hirnforsch
|
1997
|
0.75
|
86
|
Experimental check of the Gerasimov-Drell-Hearn sum rule for 1H.
|
Phys Rev Lett
|
2004
|
0.75
|
87
|
In memorium.
|
J Mol Cell Cardiol
|
2001
|
0.75
|
88
|
First Measurement of the Gerasimov-Drell-Hearn Sum Rule for 1H from 0.7 to 1.8 GeV at ELSA.
|
Phys Rev Lett
|
2003
|
0.75
|
89
|
Backscattering effects in the elastic scattering of p-polarized light from a large-amplitude random metallic grating.
|
Opt Lett
|
1989
|
0.75
|
90
|
Interaction of two optical beams at a symmetric random surface.
|
Appl Opt
|
1992
|
0.75
|
91
|
Optimisation of image reconstruction for phase-contrast x-ray Talbot-Lau imaging with regard to mechanical robustness.
|
Phys Med Biol
|
2016
|
0.75
|
92
|
Helicity dependence of gammap --> Npi below 450 MeV and contribution to the Gerasimov-Drell-Hearn sum rule.
|
Phys Rev Lett
|
2000
|
0.75
|
93
|
Endothelial nitric oxide synthase expression in heterologous systems.
|
Methods Enzymol
|
1996
|
0.75
|
94
|
Measurement of helicity-dependent photoabsorption cross sections on the neutron from 815 to 1825 MeV.
|
Phys Rev Lett
|
2005
|
0.75
|
95
|
Posttranslational modifications of endothelial nitric oxide synthase.
|
Methods Enzymol
|
1996
|
0.75
|
96
|
Epoxide adducts at the guanine residue within single-stranded DNA chains: reactivity and stability studies.
|
Nucleosides Nucleotides Nucleic Acids
|
2005
|
0.75
|
97
|
Helicity amplitudes A1/2 and A3/2 for the D13(1520) resonance obtained from the gamma-->p-->-->ppi(0) Reaction.
|
Phys Rev Lett
|
2002
|
0.75
|
98
|
High-energy x-ray Talbot-Lau radiography of a human knee.
|
Phys Med Biol
|
2017
|
0.75
|